Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
03/13/1991 | EP0185762B1 Cell-delivery agent |
03/13/1991 | CN1049864A Monoclonal antibodies against morphine and their preparation, assay box and assay method of morphine |
03/13/1991 | CA2065454A1 Use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
03/12/1991 | US4999291 Production of human pluripotent granulocyte colony-stimulating factor |
03/12/1991 | CA2023595A1 Chelating agents for forming complexes with radioactive isotopes, metal complexes thereof and use thereof in diagnosis and therapy |
03/09/1991 | WO1991003489A1 Structural alterations of the egf receptor gene in human gliomas |
03/08/1991 | CA2005917A1 Method for activating polymeric carriers and compositions prepared therefrom for use in affinity chromatography |
03/07/1991 | WO1991002978A1 Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated n-terminal amino acids |
03/07/1991 | WO1991002796A1 Cystic fibrosis gene |
03/07/1991 | WO1991002756A1 Prohormone cleavage site blocking antibody |
03/07/1991 | WO1991002751A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
03/07/1991 | WO1991002749A1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP) AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF |
03/07/1991 | WO1991002748A1 Rubella e1 peptides |
03/07/1991 | WO1991002590A2 Immunoassay to detect pseudocercosporella antigen in cereal plants |
03/07/1991 | WO1991002540A1 Compositions for the inhibition of protein hormone formation and uses thereof |
03/07/1991 | WO1991002537A1 Synthetic peptides that enhance cell binding |
03/07/1991 | DE3928861A1 Monoclonal antibodies specific for interleukin 8 - reagents for quantitative sandwich ELISA and affinity purificn. |
03/07/1991 | CA2065017A1 Peptides from gtpase-activating protein (gap) and diagnostic and therapeutic use thereof |
03/06/1991 | EP0415801A1 Monoclonal antibodies against activated microglial cells |
03/06/1991 | EP0415557A2 Separation of anti-metal chelate antibodies |
03/06/1991 | EP0415470A2 Aminopeptidase |
03/06/1991 | EP0415321A1 Oligodendrocyte cytotoxic factor |
03/06/1991 | EP0414921A1 Human monoclonal antibody reactive with pseudomonas aeruginosa, cell which produces the antibody, method of production, and pharmaceutical preparation |
03/06/1991 | EP0414807A1 Human mammary cell growth inhibitor and methods of production and use |
03/06/1991 | EP0414728A1 NOVEL NEUTROPHIL CHEMOTACTIC FACTOR, CLONED cDNA AND MONOCLONAL ANTIBODIES THERETO |
03/05/1991 | WO1991003570A1 Monoclonal antibody against infectious pancreatic nephrosis virus having neutralizing activity |
03/05/1991 | US4997929 Genetic engineering |
03/05/1991 | US4997915 Purification of pertussis toxins |
03/05/1991 | US4997913 pH-sensitive immunoconjugates and methods for their use in tumor therapy |
03/05/1991 | US4997764 Transformation of human B-lympocytes with Epstein Barr virus and c-myc containing vectors |
03/05/1991 | US4997762 Tumor associated monocoloal antibodies derived from human B-cell line |
03/05/1991 | CA2039168A1 Neutralizing monoclonal antibody to infectious pancreatic necrosis virus |
03/02/1991 | WO1991003492A1 MODIFIED HUMAN ANTI-Rh(D) ANTIBODIES |
03/02/1991 | CA2065278A1 Modified human anti-rh(d) antibodies |
03/01/1991 | WO1991003484A1 Abo genotyping |
03/01/1991 | CA2065352A1 Abo genotyping |
03/01/1991 | CA2024030A1 Oligodendrocyte cytotoxic factor |
02/27/1991 | EP0414178A2 Non-human primate CD4 polypeptides and human CD4 molecules capable of being glycosylated |
02/27/1991 | EP0413908A2 Soluble extracellular fragment of the human IFN-beta 2/IL-6 receptor, its preparation and pharmaceutical compositions containing it |
02/27/1991 | EP0413762A1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
02/26/1991 | US4996298 Marker for colorectal carcinoma and methods of detecting the same |
02/26/1991 | US4996297 contraceptives for non-rodent mammals |
02/26/1991 | US4996296 Cromolyn binding protein in highly purifed form, and methods for the isolation thereof |
02/26/1991 | US4996159 Purified polypeptides |
02/26/1991 | US4996050 Single chain pro-urokinase and plasminogin |
02/24/1991 | WO1991002977A1 Wound healing preparations containing heparanase |
02/24/1991 | WO1991002743A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof |
02/24/1991 | CA2065744A1 Wound healing preparations containing heparanase |
02/24/1991 | CA2065010A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof |
02/22/1991 | WO1991002744A1 Bone-specific protein |
02/22/1991 | CA2064878A1 Bone-specific protein |
02/21/1991 | WO1991002252A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
02/21/1991 | WO1991002250A1 Hybridomas and monoclonal antibodies therefrom having specific reactivity toward heavy chain immunoglobulin from catfish |
02/21/1991 | WO1991002079A1 Monoclonal antibodies against a tumor-associated antigen |
02/21/1991 | WO1991002078A1 Tumour necrosis factor binding ligands |
02/21/1991 | WO1991002063A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
02/21/1991 | WO1991002062A2 C-erbb-2 external domain: gp75 |
02/21/1991 | WO1991002061A1 Recombinant human thyroid peroxidase |
02/21/1991 | WO1991002058A1 Production of vascular endothelial cell growth factor |
02/21/1991 | WO1991002005A1 Natural human anti-gamma interferon antibodies detected and purified by synthetic peptides |
02/21/1991 | WO1991002004A1 IMMUNOGENIC GLYCOPROTEINS OF HUMAN CYTOMEGALOVIRUS gCII |
02/21/1991 | WO1991001754A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
02/21/1991 | WO1991001752A1 Immunosuppressive monoclonal antibodies, hybridomas and methods of transplantation |
02/21/1991 | WO1991001639A1 Methods and compositions for ameliorating the symptoms of sepsis |
02/21/1991 | WO1990015618A3 Srif-related peptides and uses thereof |
02/21/1991 | CA2060663A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
02/20/1991 | EP0413477A1 Monoclonal Antibody |
02/20/1991 | EP0413383A1 Mutants of human interleukin-3 |
02/20/1991 | EP0413188A2 Method for producung an unmodified intravenous IgM- and/or IgA-containing immunoglobulin preparation |
02/20/1991 | EP0413187A1 Method for producing an unmodified intravenous IgM- and/or IgA containing immunoglobulin preparation |
02/20/1991 | EP0412970A1 Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein |
02/19/1991 | WO1991002755A1 Fibulin |
02/19/1991 | US4994554 Probursin |
02/19/1991 | US4994553 Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies |
02/19/1991 | US4994369 T-cell activation related gene |
02/19/1991 | US4994269 Inhalation or injection via trachea |
02/19/1991 | CA2064818A1 Fibulin |
02/19/1991 | CA1280365C Radionuclide antibody coupling |
02/19/1991 | CA1280363C Peptide composition and method for the detection of antibodies to htlv-iii |
02/17/1991 | CA2020700A1 Compositions for the inhibition of protein hormone formation and uses thereof |
02/16/1991 | WO1991002747A1 Tuftsin analogs |
02/16/1991 | CA2064731A1 Tuftsin analogs |
02/16/1991 | CA2023250A1 Cleavage site blocking antibody to prohormone proteins and uses thereof |
02/13/1991 | EP0412700A1 Method for isolating fetal cytotrophoblast cells |
02/13/1991 | EP0412486A1 Antibodies to TNF binding protein I and F (ab) fragments thereof |
02/13/1991 | EP0412105A1 Stem cell inhibitors |
02/12/1991 | US4992273 Monoclonal antibodies secreted by hybridomas inhibits parasitic infections |
02/12/1991 | US4992178 Inorganic ultrafiltration of microfiltration membrane modified by a hydrophilic polymer, its preparation process and its use for the separation of proteins |
02/12/1991 | CA1280072C Antigens related to the aids virus glycoprotein envelope, especially precursors of this glycoprotein, methods for obtaining theses antigens and measures applied in these methods, applications of these antigens to the preparation of immunogen compositions or for the diagnosis of aids or related conditions |
02/07/1991 | WO1991001499A1 Method for detecting cirrhosis of the liver |
02/07/1991 | WO1991001380A1 Monoclonal antibodies directed against proteins involved in plaquettary functions, their applications as diagnostic and therapeutic agents |
02/07/1991 | WO1991001378A1 Monoclonal antibodies directed against the proenzymes of b-like cathepsine and their biological applications |
02/07/1991 | WO1991001372A1 VITAMIN K-DEPENDENT η-CARBOXYLASE |
02/07/1991 | WO1991001335A1 IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST |
02/07/1991 | WO1991001133A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
02/06/1991 | EP0412050A1 Novel cytokines |
02/06/1991 | EP0412012A1 Technetium 99m labelled polypeptides and their applications in imaging systems |
02/06/1991 | EP0411974A1 Monoclonal antibodies to a neurofibrillary tangle antigen |
02/06/1991 | EP0411893A2 Chimeric antibodies directed against a human glycoprotein antigen |
02/06/1991 | EP0411711A2 Attachment of compounds to polymeric particles using dication ethers and a kit containing same |